Alovudine

Last updated
Alovudine
Alovudine.svg
Clinical data
Other namesFluorothymidine
ATC code
  • none
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
Formula C10H13FN2O4
Molar mass 244.222 g·mol−1
3D model (JSmol)
  • O=C/1NC(=O)N(\C=C\1C)[C@@H]2O[C@@H]([C@@H](F)C2)CO
  • InChI=1S/C10H13FN2O4/c1-5-3-13(10(16)12-9(5)15)8-2-6(11)7(4-14)17-8/h3,6-8,14H,2,4H2,1H3,(H,12,15,16)/t6-,7+,8+/m0/s1 Yes check.svgY
  • Key:UXCAQJAQSWSNPQ-XLPZGREQSA-N Yes check.svgY
 X mark.svgNYes check.svgY  (what is this?)    (verify)

Alovudine (fluorothymidine) is an antiviral agent which was being developed by Medivir. It was discontinued after a Phase II trial in 2005 due to toxicity. It is a DNA polymerase inhibitor. [1]

See also

References

  1. ↑ Georgopapadakou N (January 2007). "Discontinued drugs in 2005: anti-infectives". Expert Opinion on Investigational Drugs. 16 (1): 1–10. doi:10.1517/13543784.16.1.1. PMID   17155849. S2CID   24703317.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.